Form 8-K for ResMed Inc.

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 8-K

 

CURRENT REPORT

Under Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 4, 2003 (October 28, 2003)

 


 

ResMed Inc.

(Exact Name of Registrant as Specified in Charter)

 

Delaware   0-26038   98-0152841
(State or Other Jurisdiction of
Incorporation)
  (Commission
File Number)
  (I.R.S. Employer
Identification No.)

 

14040 Danielson Street

Poway, California 92064-6857

(Address of Principal Executive Offices)

 


 

(858) 746-2400

(Registrant’s telephone number, including area code)

 



Item 7.   Financial Statements and Exhibits.

 

  (c) Exhibits

 

Exhibits:

  

Description of Document


99.1

   Transcript of Conference Call held on October 28, 2003.

 

Item 12.   Disclosure of Results of Operations and Financial Condition.

 

On October 28, 2003, we hosted a conference call to discuss the results of our operations for the quarter ended September 30, 2003. A transcript of the conference call is attached as Exhibit 99.1, and incorporated into this report by reference.

 

We are furnishing the information in this report, not “filing” it for purposes of Section 18 of the Securities Exchange Act of 1934. And we are not incorporating it by reference into any filings we’ve made before, or may make later, even though those filings may contain general incorporation language.

 

2


SIGNATURES

 

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

 

Date: November 4, 2003

      RESMED INC.
(registrant)
            By:  

/s/ Adrian M. Smith

             
           

Name:

 

Adrian M. Smith

           

Its:

 

Vice President Finance and Chief Financial Officer

 

3


EXHIBIT INDEX

 

Exhibits:

  

Description of Document


99.1

   Transcript of Conference Call held on October 28, 2003.

 

4